Inhibited prefrontal cortex oxidative stress and depression-like behavior by reducing the levels of IL-1β, IL-6, and TNF-α, microglia cell activation, HPA axis hyperactivity and lipid peroxidation, and increasing enzymes decrease. Here, IL1B is linked to depressive symptom measurement.